Effect of cyclooxygenase inhibitor use on immunotherapy efficacy in non‐small cell lung cancer

BACKGROUND: A synergistic effect of cyclooxygenase inhibitors (COX‐I) and immune checkpoint inhibitors (ICIs) has been suggested. However, the impact of COX‐I on the efficacy of ICIs is unclear. Here, we aimed to evaluate the relationship between COX‐I use and the efficacy of ICI in patients with no...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanai, Osamu, Ito, Takanori, Saito, Zentaro, Yamamoto, Yuki, Fujita, Kohei, Okamura, Misato, Hashimoto, Masayuki, Nakatani, Koichi, Sawai, Satoru, Mio, Tadashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952791/
https://www.ncbi.nlm.nih.gov/pubmed/33559253
http://dx.doi.org/10.1111/1759-7714.13845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952791/
https://www.ncbi.nlm.nih.gov/pubmed/33559253
http://dx.doi.org/10.1111/1759-7714.13845

Ejemplares similares